CN105566357A - 一种手性l-缬氨酸铜配合物的制备及合成方法 - Google Patents

一种手性l-缬氨酸铜配合物的制备及合成方法 Download PDF

Info

Publication number
CN105566357A
CN105566357A CN201610146624.3A CN201610146624A CN105566357A CN 105566357 A CN105566357 A CN 105566357A CN 201610146624 A CN201610146624 A CN 201610146624A CN 105566357 A CN105566357 A CN 105566357A
Authority
CN
China
Prior art keywords
valine
copper complex
crystal
chiral
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610146624.3A
Other languages
English (en)
Inventor
罗梅
张志军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hefei Xiangchen Chemical Engineering Co Ltd
Original Assignee
Hefei Xiangchen Chemical Engineering Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hefei Xiangchen Chemical Engineering Co Ltd filed Critical Hefei Xiangchen Chemical Engineering Co Ltd
Priority to CN201610146624.3A priority Critical patent/CN105566357A/zh
Publication of CN105566357A publication Critical patent/CN105566357A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic System
    • C07F1/005Compounds containing elements of Groups 1 or 11 of the Periodic System without C-Metal linkages
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1805Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing nitrogen
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22Organic complexes
    • B01J31/2204Organic complexes the ligands containing oxygen or sulfur as complexing atoms
    • B01J31/2208Oxygen, e.g. acetylacetonates
    • B01J31/2226Anionic ligands, i.e. the overall ligand carries at least one formal negative charge
    • B01J31/2243At least one oxygen and one nitrogen atom present as complexing atoms in an at least bidentate or bridging ligand
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38Separation; Purification; Stabilisation; Use of additives
    • C07C227/40Separation; Purification
    • C07C227/42Crystallisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/188Preparation; Treatments not provided for in C07F7/20 by reactions involving the formation of Si-O linkages
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/30Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
    • B01J2231/34Other additions, e.g. Monsanto-type carbonylations, addition to 1,2-C=X or 1,2-C-X triplebonds, additions to 1,4-C=C-C=X or 1,4-C=-C-X triple bonds with X, e.g. O, S, NH/N
    • B01J2231/3411,2-additions, e.g. aldol or Knoevenagel condensations
    • B01J2231/342Aldol type reactions, i.e. nucleophilic addition of C-H acidic compounds, their R3Si- or metal complex analogues, to aldehydes or ketones
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/30Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
    • B01J2231/34Other additions, e.g. Monsanto-type carbonylations, addition to 1,2-C=X or 1,2-C-X triplebonds, additions to 1,4-C=C-C=X or 1,4-C=-C-X triple bonds with X, e.g. O, S, NH/N
    • B01J2231/3411,2-additions, e.g. aldol or Knoevenagel condensations
    • B01J2231/342Aldol type reactions, i.e. nucleophilic addition of C-H acidic compounds, their R3Si- or metal complex analogues, to aldehydes or ketones
    • B01J2231/343Aldol type reactions, i.e. nucleophilic addition of C-H acidic compounds, their R3Si- or metal complex analogues, to aldehydes or ketones to prepare cyanhydrines, e.g. by adding HCN or TMSCN
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/02Compositional aspects of complexes used, e.g. polynuclearity
    • B01J2531/0238Complexes comprising multidentate ligands, i.e. more than 2 ionic or coordinative bonds from the central metal to the ligand, the latter having at least two donor atoms, e.g. N, O, S, P
    • B01J2531/0241Rigid ligands, e.g. extended sp2-carbon frameworks or geminal di- or trisubstitution
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/10Complexes comprising metals of Group I (IA or IB) as the central metal
    • B01J2531/16Copper
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Abstract

一种手性L-缬氨酸铜配合物晶体,其化学式如下:

Description

一种手性L-缬氨酸铜配合物的制备及合成方法
一、技术领域
本发明涉及一种新化合物,特别涉及一种手性化合物,确切地说是一种手性L-缬氨酸铜配合物的制备及合成方法。
二、背景技术
手性一水合二[L-缬氨酸]铜配合物在医药及生物领域有重要的用途,类似该化合物的结构已有文献报道[1-2]:
1.Synthesis, antimicrobial activity and cyclic voltammogram of Cu(II)complex , Li, Qiu-tong; Bo, Ying-ying; Xu, Xing-you; Duanmu, Chuan-song;Chen, Zhi-dong , Changzhou Daxue Xuebao, Ziran Kexueban (2012), 24(3), 75-79.
2.Synthesis, characterization and superoxide-​dismutase-​like activity ofCu(II) complex of L-
isoleucinate, Liao, Shengrong; Lin, Qingbin; Le, Xueyi; Feng, XiaolongHuaxue
Yanjiu (2006), 17(1), 9-12.
三、发明内容
本发明旨在提供手性一水合二[L-缬氨酸]铜配合物。所要解决的技术问题是一步合成得到目标产物。
本发明所称的一水合二[L-缬氨酸]铜配合物的制备是由L-缬氨酸与二水合氯化铜作用,由以下化学式所示的化合物:
(I)。
化学名称:一水合二[L-缬氨酸]铜配合物,简称配合物(I)。
本合成方法包括合成和分离,所述的合成是称取1.7259g(0.015mol)L-缬氨酸放入100mL圆底烧瓶中,加入40mL无水甲醇并搅拌使其溶解;将0.9051g(0.05mol)二水合氯化铜加入上述溶液,加热回流48h;反应结束后趁热过滤反应溶液,将滤渣用20mL无水甲醇和20mL蒸馏水溶解,自然挥发,几天后有蓝色晶体析出;将蓝色晶体用石油醚和正己烷冲洗3次,真空干燥30min,得目标产物。
合成反应如下:
本合成方法一步得到目标产物,工艺简单,操作方便。
该手性一水合二[L-缬氨酸]铜配合物在苯甲醛的腈硅化反应及丙酮酸乙酯的亨利反应中显示了较好的催化效果,其转化率分别为82%及90%。
四、附图说明
图1一水合二[L-缬氨酸]铜配合物的X-衍射分析图。
五、具体实施方式
称取1.7259g(0.015mol)L-缬氨酸放入100mL圆底烧瓶中,加入40mL无水甲醇并搅拌使其溶解;将0.9051g(0.05mol)二水合氯化铜加入上述溶液,加热回流48h;反应结束后趁热过滤反应溶液,将滤渣用20mL无水甲醇和20mL蒸馏水溶解,自然挥发,几天后有蓝色晶体析出。产率为31%,m.p.: >200°C, [α]20 D=-271.0°(c=0.0644,CH3OH)。元素分析数据Cu[C10H22N2O5],理论值(%):C:38.27%;H:7.07%;N:8.93%;实测值(%):C:37.89%;H:7.01%;N:8.87%;红外光谱数据(KBr, cm-1): 588, 645,794,923,1128,1382,1491,1621,2955,3289;
晶体结构数据:
经验式 C10H22 Cl2 N3 O5 Cu
分子量 313.83
温度 293(2) K
波长 0.71073 A
晶系, 空间群 单斜晶系,C2
晶胞参数 a = 21.376(5) Å α = 90°.
b = 9.686(3) Å β = 108.804(5) °.
c= 7.4209(19) Å γ = 90 °.
体积 1439.5(6)Å^3
电荷密度 4,1.448 Mg/m^3
吸收 校正参数 1.531 mm^-1
单胞内的电子数目 660
晶体大小 0.210 x 0.160 x 0.120 mm
Theta 角的范围 2.013 to 25.996°
HKL的指标收集范围 -26<=h<=17, -11<=k<11, -9<=l<=9
收集/独立衍射数据 4275 / 2525 [R(int) = 0.0363]
theta = 30.5的数据完整度 99.6 %
吸收校正的方法 多层扫描
最大最小的透过率 0.7456 and 0.5507
精修使用的方法 F^2 的矩阵最小二乘法
数据数目/使用限制的数目/参数数目 2525/95/196
精修使用的方法 1.047
衍射点的一致性因子 R1 = 0.0505,wR2= 0.1184
可观察衍射的吻合因子 R1 = 0.0555 wR2 = 0.1221
绝对构型参数 0.007(19)
差值傅里叶图上的最大峰顶和峰谷 0.735and -0.303e.A^-3
晶体典型的键长数据:
Cu(1)-O(2) 1.944(6)
Cu(1)-O(4) 1.954(6)
Cu(1)-N(2) 1.991(6)
Cu(1)-N(1) 2.001(7)
Cu(1)-O(5) 2.354(4)
N(1)-C(2) 1.492(11)
N(1)-H(1A) 0.9700
N(1)-H(1B) 0.9700
N(2)-C(7) 1.473(11)
N(2)-H(2A) 0.9700
N(2)-H(2B) 0.9700
O(1)-C(1) 1.237(11)
O(2)-C(1) 1.270(10)
O(3)-C(6) 1.227(10)
O(4)-C(6) 1.258(11)
O(5)-H(5D) 0.8110
O(5)-H(5F) 0.9271
C(1)-C(2) 1.516(15)
C(2)-C(3) 1.525(15)
C(2)-H(2) 0.9800
C(3)-C(5) 1.459(16)
C(3)-C(4) 1.470(16)
C(3)-H(3) 0.9800
C(4)-H(4A) 0.9600
C(4)-H(4B) 0.9600
C(4)-H(4C) 0.9600
C(5)-H(5A) 0.9600
C(5)-H(5B) 0.9600
C(5)-H(5C) 0.9600
C(6)-C(7) 1.527(9)
C(7)-C(8) 1.492(18)
C(7)-C(8') 1.607(19)
C(7)-H(7) 0.9800
C(8)-C(10) 1.52(2)
C(8)-C(9) 1.52(2)
C(8)-H(8) 0.9800
C(9)-H(9A) 0.9600
C(9)-H(9B) 0.9600
C(9)-H(9C) 0.9600
C(10)-H(10A) 0.9600
C(10)-H(10B) 0.9600
C(10)-H(10C) 0.9600
C(8')-C(9') 1.51(2)
C(8')-C(10') 1.54(2)
C(8')-H(8') 0.9800
C(9')-H(9'1) 0.9600
C(9')-H(9'2) 0.9600
C(9')-H(9'3) 0.9600
C(10')-H(10D) 0.9600
C(10')-H(10E) 0.9600
C(10')-H(10F) 0.9600
晶体典型的键角数据:
O(2)-Cu(1)-O(4) 90.6(2)
O(2)-Cu(1)-N(2) 171.3(3)
O(4)-Cu(1)-N(2) 83.6(2)
O(2)-Cu(1)-N(1) 84.0(3)
O(4)-Cu(1)-N(1) 162.7(3)
N(2)-Cu(1)-N(1) 99.8(3)
O(2)-Cu(1)-O(5) 98.0(2)
O(4)-Cu(1)-O(5) 108.7(2)
N(2)-Cu(1)-O(5) 90.0(3)
N(1)-Cu(1)-O(5) 88.4(3)
C(2)-N(1)-Cu(1) 110.3(5)
C(2)-N(1)-H(1A) 109.6
Cu(1)-N(1)-H(1A) 109.6
C(2)-N(1)-H(1B) 109.6
Cu(1)-N(1)-H(1B) 109.6
H(1A)-N(1)-H(1B) 108.1
C(7)-N(2)-Cu(1) 110.9(5)
C(7)-N(2)-H(2A) 109.5
Cu(1)-N(2)-H(2A) 109.5
C(7)-N(2)-H(2B) 109.5
Cu(1)-N(2)-H(2B) 109.5
H(2A)-N(2)-H(2B) 108.0
C(1)-O(2)-Cu(1) 116.8(6)
C(6)-O(4)-Cu(1) 116.4(5)
Cu(1)-O(5)-H(5D) 126.0
Cu(1)-O(5)-H(5F) 104.6
H(5D)-O(5)-H(5F) 114.9
O(1)-C(1)-O(2) 123.9(9)
O(1)-C(1)-C(2) 118.3(8)
O(2)-C(1)-C(2) 117.7(8)
N(1)-C(2)-C(1) 110.0(7)
N(1)-C(2)-C(3) 116.5(9)
C(1)-C(2)-C(3) 111.3(9)
N(1)-C(2)-H(2) 106.1
C(1)-C(2)-H(2) 106.1
C(3)-C(2)-H(2) 106.1
C(5)-C(3)-C(4) 113.1(13)
C(5)-C(3)-C(2) 112.1(11)
C(4)-C(3)-C(2) 113.5(12)
C(5)-C(3)-H(3) 105.8
C(4)-C(3)-H(3) 105.8
C(2)-C(3)-H(3) 105.8
C(3)-C(4)-H(4A) 109.5
C(3)-C(4)-H(4B) 109.5
H(4A)-C(4)-H(4B) 109.5
C(3)-C(4)-H(4C) 109.5
H(4A)-C(4)-H(4C) 109.5
H(4B)-C(4)-H(4C) 109.5
C(3)-C(5)-H(5A) 109.5
C(3)-C(5)-H(5B) 109.5
H(5A)-C(5)-H(5B) 109.5
C(3)-C(5)-H(5C) 109.5
H(5A)-C(5)-H(5C) 109.5
H(5B)-C(5)-H(5C) 109.5
O(3)-C(6)-O(4) 122.9(8)
O(3)-C(6)-C(7) 119.6(8)
O(4)-C(6)-C(7) 117.5(8)
N(2)-C(7)-C(8) 119.5(11)
N(2)-C(7)-C(6) 109.2(7)
C(8)-C(7)-C(6) 115.7(11)
N(2)-C(7)-C(8') 107.3(10)
C(6)-C(7)-C(8') 105.7(10)
N(2)-C(7)-H(7) 103.5
C(8)-C(7)-H(7) 103.4
C(6)-C(7)-H(7) 103.2
C(7)-C(8)-C(10) 109.1(16)
C(7)-C(8)-C(9) 107.3(15)
C(10)-C(8)-C(9) 114.0(19)
C(7)-C(8)-H(8) 108.8
C(10)-C(8)-H(8) 108.8
C(9)-C(8)-H(8) 108.8
C(8)-C(9)-H(9A) 109.5
C(8)-C(9)-H(9B) 109.5
H(9A)-C(9)-H(9B) 109.5
C(8)-C(9)-H(9C) 109.5
H(9A)-C(9)-H(9C) 109.5
H(9B)-C(9)-H(9C) 109.5
C(8)-C(10)-H(10A) 109.5
C(8)-C(10)-H(10B) 109.5
H(10A)-C(10)-H(10B) 109.5
C(8)-C(10)-H(10C) 109.5
H(10A)-C(10)-H(10C) 109.5
H(10B)-C(10)-H(10C) 109.5
C(9')-C(8')-C(10') 109.0(16)
C(9')-C(8')-C(7) 117.0(16)
C(10')-C(8')-C(7) 110.5(16)
C(9')-C(8')-H(8') 106.6
C(10')-C(8')-H(8') 106.6
C(7)-C(8')-H(8') 106.6
C(8')-C(9')-H(9'1) 109.5
C(8')-C(9')-H(9'2) 109.5
H(9'1)-C(9')-H(9'2) 109.5
C(8')-C(9')-H(9'3) 109.5
H(9'1)-C(9')-H(9'3) 109.5
H(9'2)-C(9')-H(9'3) 109.5
C(8')-C(10')-H(10D) 109.5
C(8')-C(10')-H(10E) 109.5
H(10D)-C(10')-H(10E) 109.5
C(8')-C(10')-H(10F) 109.5
H(10D)-C(10')-H(10F) 109.5
H(10E)-C(10')-H(10F) 109.5
腈硅化反应应用
2-苯基-2-(三甲硅氧基)丙腈
0.0314g(0.1mmol)L-缬氨酸铜配合物(Ⅷ),再加入2mL 四氢呋喃、0.3mL 三甲基硅腈和0.1mL苯甲醛,常温搅拌72h后,进行1HNMR检测, 转化率:82 %; 1H NMR (300MHz, CDCl3)7.56–7.59 (m, 0.9 Hz, 2H), 7.31–7.34 (m, 3H), 5.43 (s, 1H), 0.16 (s, 9H). 13CNMR (75 MHz, CDCl3) 136.1, 128.8(x2), 126.2(x2), 119.1, 63.5, -0.39(x3)。
亨利反应应用
0.0235g(7.5%mmol)配合物(Ⅷ),置于25mL烧瓶中,依次加入0.5mL 苯甲醛, 1mL四氢呋喃、0.25mL硝基甲烷和0.015mL丙酮酸乙酯,常温搅拌反应6h,分别取样进行1HNMR检测,其转化率为90%; 1 H NMR (CDCl 3 ): δ=4.86 (d,J =13.8 Hz, 1H), 4.58 (d, J =13.8Hz, 1H), 4.34 (m, 2H), 3.85(s, 1H), 1.46 (s, 3H), 1.33 (t, J ) 7.2 Hz, 3H);13C NMR (CDCl 3 ):δ=173.4, 80.9, 72.4, 63.0, 23.8, 13.9。

Claims (3)

1.一种手性L-缬氨酸铜配合物晶体,其化学式如下:
(I)。
2.权利要求1所述的手性L-缬氨酸铜配合物晶体(I),在293(2) K 温度下,在 牛津X-射线单晶衍射仪上,用经石墨单色器单色化的MoKα射线λ=0.71073 Å, 以ω-θ 扫描方式收集衍射数据,其特征在于晶体属单斜晶系, C2;晶胞参数a = 21.376(5) Å α = 90°;b =9.686(3) Å β = 108.804(5) °;c = 7.4209(19) Å γ = 90 °。
3.权利要求1所述的手性L-缬氨酸铜配合物晶体(I)的合成方法,包括合成和分离,所述的合成所述的合成是称取1.7259g(0.015mol)L-缬氨酸放入100mL圆底烧瓶中,加入40mL无水甲醇,搅拌使其溶解;将0.9051g(0.05mol)二水合氯化铜加入上述溶液,加热回流48h;反应结束后趁热过滤反应溶液,将滤渣用20mL无水甲醇和20mL蒸馏水溶解,自然挥发,几天后有蓝色晶体析出;将蓝色晶体用石油醚和正己烷冲洗3次,真空干燥30min,得目标产物。
CN201610146624.3A 2016-03-15 2016-03-15 一种手性l-缬氨酸铜配合物的制备及合成方法 Pending CN105566357A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610146624.3A CN105566357A (zh) 2016-03-15 2016-03-15 一种手性l-缬氨酸铜配合物的制备及合成方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610146624.3A CN105566357A (zh) 2016-03-15 2016-03-15 一种手性l-缬氨酸铜配合物的制备及合成方法

Publications (1)

Publication Number Publication Date
CN105566357A true CN105566357A (zh) 2016-05-11

Family

ID=55877046

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610146624.3A Pending CN105566357A (zh) 2016-03-15 2016-03-15 一种手性l-缬氨酸铜配合物的制备及合成方法

Country Status (1)

Country Link
CN (1) CN105566357A (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110897039A (zh) * 2019-12-26 2020-03-24 长沙兴嘉生物工程股份有限公司 一种缬氨酸锰的制备方法及其应用
CN112624933A (zh) * 2020-12-31 2021-04-09 河北力维素科技有限公司 一种支链氨基酸螯合铜的制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102596882A (zh) * 2009-09-02 2012-07-18 纳幕尔杜邦公司 用于芳族酸的氟化醚的合成方法
CN103275108A (zh) * 2013-06-26 2013-09-04 罗梅 一种手性铜配合物制备及合成方法
CN103285924A (zh) * 2013-07-03 2013-09-11 罗梅 一种手性铜配合物的用途
CN103450229A (zh) * 2013-07-29 2013-12-18 罗梅 一种手性铜配合物的用途
CN103570751A (zh) * 2013-10-26 2014-02-12 合肥工业大学 一种手性亮氨醇铜配合物

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102596882A (zh) * 2009-09-02 2012-07-18 纳幕尔杜邦公司 用于芳族酸的氟化醚的合成方法
CN103275108A (zh) * 2013-06-26 2013-09-04 罗梅 一种手性铜配合物制备及合成方法
CN103285924A (zh) * 2013-07-03 2013-09-11 罗梅 一种手性铜配合物的用途
CN103450229A (zh) * 2013-07-29 2013-12-18 罗梅 一种手性铜配合物的用途
CN103570751A (zh) * 2013-10-26 2014-02-12 合肥工业大学 一种手性亮氨醇铜配合物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
何美等: "铜-二肽(氨基酸)二元配合物的稳定性研究", 《沈阳化工学院学报》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110897039A (zh) * 2019-12-26 2020-03-24 长沙兴嘉生物工程股份有限公司 一种缬氨酸锰的制备方法及其应用
CN110897039B (zh) * 2019-12-26 2023-02-03 长沙兴嘉生物工程股份有限公司 一种缬氨酸锰的制备方法及其应用
CN112624933A (zh) * 2020-12-31 2021-04-09 河北力维素科技有限公司 一种支链氨基酸螯合铜的制备方法

Similar Documents

Publication Publication Date Title
CN102887912B (zh) 一种手性锌配合物
CN105859774A (zh) 一种膦苯类化合物的制备方法
WO2021253847A1 (zh) 脱质子苯基桥连β - 酮亚胺锂化合物在硼氢化反应中的应用
CN105566357A (zh) 一种手性l-缬氨酸铜配合物的制备及合成方法
CN103342710A (zh) 一种手性锌配合物
CN107253923A (zh) 一种乙酰脲二聚体晶体化合物的合成方法及用途
CN105175453A (zh) 一种锰配合物制备及其合成方法
CN103193808A (zh) 一种手性锌配合物
CN103275108B (zh) 一种手性铜配合物制备及合成方法
CN102936204A (zh) 一种手性化合物
CN105001268A (zh) 一种手性噁唑啉铂配合物晶体及其合成方法
Fang et al. An unusual (4, 10)-connected 3-D metal–organic framework based on non-planar tricarboxyl tecton and tetracadmium (ii) secondary building units
CN105237413A (zh) 一种手性含结晶水苯甘氨醇钴配合物
Wang et al. Half-sandwich scandium boryl complexes bearing a silylene-linked cyclopentadienyl-amido ligand
CN101219988A (zh) 一种4,4′-二取代基-2,2′-联吡啶的合成方法
CN109836457B (zh) 一种高位阻手性p,n,n配体及其制备方法和应用
CN103709204B (zh) 一种钴配合物、制备方法及其用途
CN112961179B (zh) 一种硼硅氧烷类化合物的制备方法
CN104496929A (zh) 一种含氯仿结晶的手性锌配合物晶体及用途
CN103304586B (zh) 一种手性铜配合物
CN103804429B (zh) 一种手性亮氨醇钴配合物
CN103570765B (zh) 一种手性噁唑啉锰配合物晶体及其合成方法
CN103012445B (zh) 一种手性锌配合物
CN106117178A (zh) 一种钴配合物
CN105218473A (zh) 一种含甲醇结晶的手性锌配合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160511

RJ01 Rejection of invention patent application after publication